Table Of Contents
1 Introduction 12
1.1 Objectives Of The Study 12
1.2 Market Definition 12
1.3 Overview Of Middle East And Africa Wound Debridement Devices Market 12
1.4 Currency And Pricing 13
1.5 Limitation 13
1.6 Markets Covered 13
2 Market Segmentation 16
2.1 Markets Covered 16
2.2 Geographic Scope 17
2.3 Years Considered For The Study 18
2.4 Currency And Pricing 18
2.5 Research Methodology 19
2.6 Primary Interviews With Key Opinion Leaders 22
2.7 Secondary Sources 23
2.8 Assumptions 23
3 Executive Summary 24
4 Premium Insights 26
5 Market Overview 29
5.1 Drivers 31
5.1.1 Increasing Number Of Diabetes And Related Wounds 31
5.1.2 Increasing Geriatric Population 32
5.1.3 Increasing Incidence Of Burn Cases 33
5.1.4 Increasing Awareness Towards Wound Care Management 34
5.1.5 Favorable Reimbursement Scenario 35
5.2 Restraints 36
5.2.1 High Cost Of Advanced Wound Debridement Products 36
5.3 Opportunities 37
5.3.1 Increasing Growth In Emerging Market 37
5.4 Challenges 37
5.4.1 Focus On Autolytic Debridement & Disposable Products 37
6 Middle East And Africa Wound Debridement Devices Market, By Product 38
6.1 Overview 39
6.2 Hydrosurgical 41
6.3 Low-Frequency Ultrasound 42
6.4 Mechanical 43
6.4.1 Monofilament Fiber Pad 44
6.4.2 Gauze 44
6.4.3 Paraffin Tulle 44
6.4.4 Wet-To-Dry Debridement 44
6.5 Larval Therapy 45
6.6 Others 46
7 Middle East And Africa Wound Debridement Devices Market, By Method 47
7.1 Overview 48
7.2 Autolytic 50
7.3 Enzymatic 51
7.4 Surgical 52
7.5 Mechanical 53
7.6 Maggot 54
8 Middle East And Africa Wound Debridement Devices Market, By Wound Type 55
8.1 Overview 56
8.2 Diabetic Ulcers 58
8.3 Pressure Ulcers 59
8.4 Venous Ulcers 60
8.5 Surgical Wounds 61
8.6 Burns 62
8.7 Others 63
9 Middle East And Africa Wound Debridement Devices Market, By End User 64
9.1 Overview 65
9.2 Hospitals 67
9.3 Ambulatory Centers 68
9.4 Clinics 69
9.5 Home Healthcare 70
9.6 Wound Care Centers 71
9.7 Community Healthcare 72
10 Middle East And Africa Wound Debridement Devices Market, By Geography 73
10.1 Middle East & Africa 73
10.1.1 Saudi Arabia 80
10.1.2 South Africa 83
10.1.3 Uae 86
10.1.4 Rest Of Middle East & Africa 89
11 Middle East And Africa Wound Debridement Devices Market, Company Landscape 90
11.1 Company Share Analysis; Middle East And Africa 90
12 Company Profile 91
12.1 Smith & Nephew Plc 91
12.1.1 Company Overview 91
12.1.2 Revenue Analysis 91
12.1.3 Company Share Analysis 92
12.1.4 Product Portfolio 92
12.1.5 Recent Development 93
12.2 Integra Lifescience 94
12.2.1 Company Overview 94
12.2.2 Revenue Analysis 94
12.2.3 Company Share Analysis 95
12.2.4 Product Portfolio 95
12.2.5 Recent Development 96
12.3 Zimmer Biomet 97
12.3.1 Company Overview 97
12.3.2 Revenue Analysis 98
12.3.3 Company Share Analysis 98
12.3.4 Product Portfolio 99
12.3.5 Recent Development 99
12.4 Advanced Medical Solutions Plc 100
12.4.1 Company Overview 100
12.4.2 Revenue Analysis 100
12.4.3 Product Portfolio 101
12.4.4 Recent Development 101
12.5 Advancis Medical 102
12.5.1 Company Overview 102
12.5.2 Geographical Presence; Advancis Medical 102
12.5.3 Product Portfolio 103
12.5.4 Recent Development 104
12.6 Arobella Medical, Llc 105
12.6.1 Company Overview 105
12.6.2 Product Portfolio 105
12.6.3 Recent Development 105
12.7 B. Braun Melsungen Ag 106
12.7.1 Company Overview 106
12.7.2 Revenue Analysis 107
12.7.3 Product Portfolio 107
12.7.4 Recent Development 108
12.8 Biomonde 109
12.8.1 Overview 109
12.8.2 Gepgraphical Presence; Biomonde 109
12.8.3 Product Portfolio 110
12.8.4 Recent Development 110
12.9 Bsn Medical 111
12.9.1 Company Overview 111
12.9.2 Gepgraphical Presence; Bsn Medical 111
12.9.3 Product Portfolio 112
12.9.4 Recent Development 113
12.10 Coloplast 114
12.10.1 Company Overview 114
12.10.2 Revenue Analysis 114
12.10.3 Product Portfolio 115
12.10.4 Recent Development 115
12.11 Deroyal Industries, Inc 116
12.11.1 Company Overview 116
12.11.2 Geographical Presence; Deroyal Industries, Inc 116
12.11.3 Product Portfolio 117
12.11.4 Recent Development 117
12.12 Hollister Incorporated 118
12.12.1 Company Overview 118
12.12.2 Geographical Presence; Hollister Incorporated 118
12.12.3 Product Portfolio 119
12.12.4 Recent Development 119
12.13 Italia Medica Srl 120
12.13.1 Company Overview 120
12.13.2 Product Portfolio 120
12.13.3 Recent Development 120
12.14 Lohmann & Rauscher Gmbh 121
12.14.1 Company Overview 121
12.14.2 Gepgraphical Presence; Lohmann & Rauscher Gmbh 121
12.14.3 Product Portfolio 122
12.14.4 Recent Development 122
12.15 Medtronic 123
12.15.1 Company Overview 123
12.15.2 Revenue Analysis 123
12.15.3 Product Portfolio 124
12.15.4 Recent Development 124
12.16 Misonix 125
12.16.1 Company Overview 125
12.16.2 Revenue Analysis 125
12.16.3 Product Portfolio 126
12.16.4 Recent Development 126
12.17 Molnlycke Healthcare 127
12.17.1 Company Overview 127
12.17.2 Geographical Presence; Molnlycke Healthcare 127
12.17.3 Product Portfolio 128
12.17.4 Recent Development 128
12.18 Organogenesis Inc 129
12.18.1 Company Overview 129
12.18.2 Gepgraphical Presence; Organogenesis 129
12.18.3 Product Portfolio 130
12.18.4 Recent Development 130
12.19 Olympus Corporation 131
12.19.1 Company Overview 131
12.19.2 Revenue Analysis 132
12.19.3 Product Portfolio 132
12.19.4 Recent Development 132
12.20 S?ring Gmbh 133
12.20.1 Company Overview 133
12.20.2 Gepgraphical Presence; S?ring Gmbh 133
12.20.3 Product Portfolio 134
12.20.4 Recent Development 134
13 Related Reports 135
?